新型冠状病毒肺炎(COVID-19)大流行对人类免疫缺陷病毒(HIV)传播的潜在影响:美国32个城市的建模研究
该建模研究使用约翰霍普金斯流行病学与经济模型预测2020至2025年美国32个都市统计区的HIV感染情况,模拟COVID-19对性传播、病毒抑制、HIV检测和暴露前预防的不同影响。结果显示2020年诊断报告下降后2021或2022年反弹;若性传播2021年7月前恢复、HIV照护2022年1月前恢复,则2020至2025年感染数较无COVID-19时多1161例(1%)。乐观模拟下发病率低8%(95%可信区间:低14%至无变化),悲观模拟下发病率高11%(高1%至21%)。
要点
- 2020年HIV诊断报告可能下降,2021或2022年反弹,与真实发病率相关性差。
- 若性传播2021年7月前恢复、HIV照护2022年1月前恢复,2020至2025年感染数较无疫情时多1161例(1%)。
- 乐观模拟发病率低8%(95%可信区间:低14%至无变化),悲观模拟发病率高11%(高1%至21%)。
核心结论
- COVID-19对HIV传播的影响仍不确定且因城市而异。
- 2020至2021年报告的HIV诊断可能难以反映真实发病率。
- 尽量减少对HIV照护的干扰对减轻COVID-19对HIV传播的负面影响至关重要。
研究设计与样本
- 使用约翰霍普金斯流行病学与经济模型预测2020至2025年美国32个都市统计区(MSA)的HIV感染。
- 对COVID-19影响性传播(降低0-50%)、HIV感染者病毒抑制(降低0-40%)、HIV检测(降低0-50%)和暴露前预防使用(降低0-30%)进行抽样,并按时间索引至谷歌社区移动报告。
主要发现
- 模拟预测2020年报告诊断下降,2021或2022年反弹,与基础发病率无关。
- 若性传播2021年7月前恢复且HIV照护2022年1月前恢复,2020至2025年全部32个城市感染数较无COVID-19时多1161例(1%)。
- 乐观模拟中性传播急剧减少且病毒抑制维持,预测发病率低8%(95%可信区间:低14%至无变化)。
- 悲观模拟中性传播基本不变但病毒抑制下降,预测发病率高11%(高1%至21%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The degree to which the 2019 novel coronavirus disease (COVID-19) pandemic will affect the US human immunodeficiency virus (HIV) epidemic is unclear. METHODS: We used the Johns Hopkins Epidemiologic and Economic Model to project HIV infections from 2020 to 2025 in 32 US metropolitan statistical areas (MSAs). We sampled a range of effects of the pandemic on sexual transmission (0-50% reduction), viral suppression among people with HIV (0-40% reduction), HIV testing (0-50% reduction), and pre-exposure prophylaxis use (0-30% reduction), and indexed reductions over time to Google Community Mobility Reports. RESULTS: Simulations projected reported diagnoses would drop in 2020 and rebound in 2021 or 2022, regardless of underlying incidence. If sexual transmission normalized by July 2021 and HIV care normalized by January 2022, we projected 1161 (1%) more infections from 2020 to 2025 across all 32 cities than if COVID-19 had not occurred. Among "optimistic" simulations in which sexual transmission was sharply reduced and viral suppression was maintained we projected 8% lower incidence (95% credible interval: 14% lower to no change). Among "pessimistic" simulations where sexual transmission was largely unchanged but viral suppression fell, we projected 11% higher incidence (1-21% higher). MSA-specific projections are available at www.jheem.org?covid. CONCLUSIONS: The effects of COVID-19 on HIV transmission remain uncertain and differ between cities. Reported diagnoses of HIV in 2020-2021 are likely to correlate poorly with underlying incidence. Minimizing disruptions to HIV care is critical to mitigating negative effects of the COVID-19 pandemic on HIV transmission.
引用
- Fojo A, Wallengren E, Schnure M, et al. Potential Effects of the Coronavirus Disease 2019 (COVID-19) Pandemic on Human Immunodeficiency Virus (HIV) Transmission: A Modeling Study in 32 US Cities. Clin Infect Dis. 2022. PMID: 35016216. doi:10.1093/cid/ciab1029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。